427
Views
47
CrossRef citations to date
0
Altmetric
Laser treatment

Low-dose 1064-nm Q-switched Nd:YAG laser for the treatment of melasma

, , , , , , & show all
Pages 224-228 | Received 01 Aug 2009, Accepted 24 Sep 2009, Published online: 30 May 2010
 

Abstract

Background: Melasma is a common acquired pigmentary disorder which is sometimes hard to treat with conventional methods. Various kinds of modalities have been applied for the treatment of melasma but none shows constantly good results. Objectives: In this study, we would like to know the effect of low-dose 1064-nm Q-switched Nd:YAG laser (QSNYL) on melasma and want to evaluate the changes of skin after laser treatment. Methods: Twenty melasma patients were enrolled. Two regions were evaluated from each patient; a total of 40 sites. The 1064-nm QSNYL at fluences of 2.0–3.5 J/cm2 was used to treat the whole face, including the melasma lesions. The fluence was adjusted individually and increased until erythema was developed on the laser-treated area. The treatment was performed five times with a 1-week interval. Non-invasive measuring methods, including a chromatometer, mexameter, cutometer, visioscan and a corneometer, were used before and after treatment. Results: The L-value from the chromatometer, which reflects the lightness of skin, was increased (0.86 ± 1.67, p < 0.05). The melanin index from the mexameter was significantly decreased (–28.23 ± 28.21, p < 0.001). The SEw value from the visioscan, which reflects the degree of wrinkling, decreased (–5.80 ± 0.59, p = 0.040). None of the other measurement parameters showed significant changes. Conclusions: Low-dose 1064-nm QSNYL appears to be an effective treatment modality for melasma.

Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.